Simplex Trading’s Rani Therapeutics RANI Stock Holding History

Simplex Trading’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,000	Closed	-$4.05K	–	9943
2025 Q4	$4.05K	Buy	+3,000	New	+$4.53K	﹤0.01%	7541
2025 Q2	–	Sell	-1,100	Closed	-$1K	–	9550
2025 Q1	$1K	Buy	1,100 +100	+10%	+$148	﹤0.01%	8290
2024 Q4	$1K	Sell	1,000 -2,500	-71%	-$5.25K	﹤0.01%	8297
2024 Q3	$7K	Sell	3,500 -100	-3%	-$287	﹤0.01%	7452
2024 Q2	$13K	Sell	3,600 -4,600	-56%	-$23.8K	﹤0.01%	7260
2024 Q1	$25K	Hold	8,200	–	–	﹤0.01%	6920
2023 Q4	$27K	Buy	8,200 +100	+1%	+$231	﹤0.01%	6673
2023 Q3	$17K	Sell	8,100 -2,900	-26%	-$11.1K	﹤0.01%	6770
2023 Q2	$45K	Buy	11,000 +10,000	+1,000%	+$46.4K	﹤0.01%	5949
2023 Q1	$5K	Hold	1,000	–	–	﹤0.01%	8067
2022 Q4	$5K	Buy	+1,000	New	+$7.29K	﹤0.01%	8089

Other funds holding RANI

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCP

SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM

Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Simplex Trading's RANI Position: Q1 2026 in Review

Simplex Trading opened a new position in Rani Therapeutics (RANI) in Q1 2026: 10,101 shares worth $7.42K. The stake represents ﹤0.01% of the portfolio and ranks #7609 among its holdings. This is a return to the name: Simplex Trading previously reported a position in RANI as recently as Q3 2025.

Simplex Trading first reported a position in RANI in Q3 2022 and has held it in 11 quarters since. The position peaked at $30K in Q4 2023. 74 funds tracked by Wall St. Rank hold RANI as of Q1 2026.

Simplex Trading held 10,101 shares of Rani Therapeutics worth $7.42K as of Q1 2026.
Rani Therapeutics was a new Simplex Trading position in Q1 2026.
Rani Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7609 holding.
Simplex Trading first reported a position in Rani Therapeutics in Q3 2022 and has held it in 11 quarters since.
Simplex Trading's Rani Therapeutics position peaked at $30K in Q4 2023.
74 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.